Anthropic appoints Indian-origin Novartis CEO Vas Narasimhan to its board - The Economic Times

Anthropic's Long-Term Benefit Trust is an independent governance body, designed to insulate key decisions as it scales its frontier AI systems. Narasimhan brings deep experience at the intersection of medicine, regulation, and global health. As the chief executive of Novartis, he has overseen the development and approval of more than 35 novel medicines.